National service lines are often built to solve one of the most persistent challenges in large health systems: how to turn enterprise scale into consistent clinical execution.
Health systems across the country have increasingly invested in national service line models as they pursue clinical integration across growing enterprise networks. The strategic rationale is clear: standardized care pathways, aligned specialty leadership, coordinated investment strategies, and enterprise-wide performance models should allow systems to improve quality, reduce variation, and scale more effectively across markets, thereby achieving the benefits of large-scale mergers.
Yet many organizations have discovered that building national service line structures is far easier than operationalizing them.
Based on my experience leading national service line development, one lesson has become increasingly clear: clinical integration is not achieved through governance structures alone. It depends on whether the organization has developed the operational capabilities required to execute consistently across markets that historically functioned independently.
Many systems have built enterprise service line structures. Far fewer have redesigned the operating model necessary to support them.
Why organizations struggle
Most health systems pursuing national service lines face a similar challenge: enterprise strategy and operational execution often evolve separately.
In many organizations, enterprise service line leaders are responsible for defining specialty growth priorities, clinical standards, and long-term transformation strategies. However, many of the operational levers required to implement those priorities, such as capital deployment, workforce planning, ambulatory expansion, and access redesign, remain locally managed.
This creates structural tension between enterprise alignment and local operational realities. Organizations may agree strategically on the need to standardize care pathways, expand longitudinal care models, or optimize site-of-care delivery, yet implementation frequently varies by market depending on infrastructure maturity, financial pressures, and regional priorities.
Over time, service lines can unintentionally become coordinating structures rather than enterprise operating capabilities.
Matrixed leadership models often add additional complexity. Many health systems rely on matrixed structures to align enterprise specialty strategy with regional operations. While these models can improve collaboration, they also require clearly defined decision rights and accountability structures to function effectively at scale.
Without that clarity, organizations often default to consensus-based governance processes that are difficult to sustain across large enterprises.
Infrastructure fragmentation can create additional barriers to integration. Data definitions, reporting structures, care coordination workflows, and access models frequently evolve differently across markets, limiting the organization’s ability to measure performance consistently or scale operational best practices effectively.
At the same time, incentives often continue to reinforce local optimization. Market leaders are typically evaluated on regional financial and operational performance, while enterprise service lines are tasked with advancing coordination, standardization, and long-term value creation across the system.
Clinical integration becomes difficult to sustain when those objectives are not aligned.
What stronger execution requires
Organizations making meaningful progress with national service lines are approaching integration differently. Rather than viewing service lines primarily as governance overlays, they are building enterprise operating capabilities that align strategy, execution, infrastructure, and accountability.
This requires four practical shifts.
First, systems need to start with execution realities, not just strategy.
In large multi-market systems, planning must extend beyond strategic vision-setting. Effective organizations use planning as a mechanism to align enterprise leadership, market operators, frontline teams, and functional stakeholders around a common operational direction.
This process helps surface implementation realities early, including infrastructure gaps, operational constraints, market readiness, and investment sequencing needs.
In practice, successful clinical integration depends less on centralized control and more on structured alignment between enterprise priorities and local execution.
Second, governance must be useful for decisions.
Many systems create councils and committees to bring stakeholders together. That alignment is important, but it is not enough. High-performing systems increasingly use governance to clarify ownership around strategic priorities, operational standards, investment sequencing, and performance accountability.
As organizations transition toward matrixed operating environments, governance clarity becomes increasingly important. Enterprise transformation requires the ability to make consistent decisions across markets while still allowing flexibility for local operational realities.
Third, organizations need to build the foundation before scaling transformation.
Infrastructure development is critical. Organizations making meaningful progress often begin by building foundational capabilities before attempting to scale broader transformation initiatives. These capabilities typically include standardized clinical pathways, aligned performance metrics, coordinated navigation models, enterprise reporting structures, and integrated access strategies.
This baseline infrastructure allows systems to create operational consistency before scaling more advanced models involving digital transformation, longitudinal specialty care strategies, or value-based reimbursement arrangements.
Technology plays an important role in enabling this work, but technology alone does not create integration. Its value emerges when it supports standardized workflows, coordinated care delivery, and enterprise-wide operational visibility.
Fourth, access and accountability must be treated as part of the operating model.
Access strategy has become another defining component of scalable clinical integration.
Historically, many organizations approached access primarily through scheduling optimization. Increasingly, health systems are recognizing that access functions as a core component of the care model itself.
Integrated access models now include centralized navigation, referral coordination, triage standardization, and site-of-care optimization designed to support coordinated patient journeys across ambulatory, community, tertiary, and quaternary settings.
Similarly, organizations are increasingly reevaluating how incentives support enterprise transformation.
Systems making sustained progress tend to align performance expectations across both enterprise and regional leadership structures, balancing local operational accountability with broader goals around standardization, coordination, and longitudinal value creation.
This alignment becomes particularly important as healthcare delivery continues shifting toward models centered on outcomes, coordinated care management, and total cost of care performance.
The future of clinical integration
National service lines remain an important mechanism for enabling enterprise clinical integration. However, their success ultimately depends on more than organizational structure.
The organizations making the greatest progress are those redesigning how strategy, governance, infrastructure, and execution operate together across the enterprise.
As healthcare delivery becomes increasingly coordinated and value-driven, clinical integration will depend less on whether systems establish enterprise service line structures and more on whether they develop the operational capabilities required to sustain enterprise performance at scale.
The future will belong to organizations that move beyond alignment in principle and build operating models capable of delivering coordinated execution across markets.
Photo: 9amstock, Getty Images
Romila Aloysius is a healthcare strategy and operations executive and currently serves as Executive Director of the Heart, Lung and Vascular Institute at Advent Health. Her work spans enterprise service line planning, national service line development, first-of-its-kind national payer-provider strategic arrangements, and operational transformation across large health systems. With an early foundation in biomedical engineering and a longstanding interest in biomedical innovation in cardiology, she works at the intersection of clinical strategy, innovation, corporate governance, financial strategy, and large-scale execution. Her experience includes roles at Cleveland Clinic, Advocate Health, and AdventHealth, with work focused on specialty care growth, specialty contracting, product development, value-based care, access strategy, capital planning, and cross-market clinical integration. She writes on healthcare strategy, specialty care transformation, payer-provider alignment, and operating models for clinical integration.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
